99 related articles for article (PubMed ID: 12937658)
21. Anticoagulation therapy in children.
Revel-Vilk S; Chan AK
Semin Thromb Hemost; 2003 Aug; 29(4):425-32. PubMed ID: 14517754
[TBL] [Abstract][Full Text] [Related]
22. Clinical trials of new anticoagulants.
Anderson J; O'Donnell M
Vnitr Lek; 2006 Mar; 52 Suppl 1():123-6. PubMed ID: 16637460
[TBL] [Abstract][Full Text] [Related]
23. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
24. Antithrombotics in thrombosis and cancer.
Mousa SA
Hamostaseologie; 2005 Nov; 25(4):380-6. PubMed ID: 16395488
[TBL] [Abstract][Full Text] [Related]
25. Effect of low molecular weight fucoidan and low molecular weight heparin in a rabbit model of arterial thrombosis.
Durand E; Helley D; Al Haj Zen A; Dujols C; Bruneval P; Colliec-Jouault S; Fischer AM; Lafont A
J Vasc Res; 2008; 45(6):529-37. PubMed ID: 18463418
[TBL] [Abstract][Full Text] [Related]
26. Abstracts. Joint meeting of the International Committee on Thrombosis and Haemostasis, 32nd annual meeting, and the Mediterranean League against Thromboembolic Diseases, 9th congress. Jerusalem, Israel, June 1-6, 1986.
Thromb Res Suppl; 1986; 6():1-191. PubMed ID: 3458328
[No Abstract] [Full Text] [Related]
27. Thromboprophylaxis in immobilized medical patients.
Vaitkus PT
Eur J Med Res; 2004 Mar; 9(3):131-4. PubMed ID: 15096323
[TBL] [Abstract][Full Text] [Related]
28. From heparins to factor Xa inhibitors and beyond.
Alban S
Eur J Clin Invest; 2005 Mar; 35 Suppl 1():12-20. PubMed ID: 15701143
[TBL] [Abstract][Full Text] [Related]
29. The safety of heparins in end-stage renal disease.
Sonawane S; Kasbekar N; Berns JS
Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
[TBL] [Abstract][Full Text] [Related]
30. Management options for thrombophilias.
Gallus AS
Semin Thromb Hemost; 2005 Feb; 31(1):118-26. PubMed ID: 15706484
[TBL] [Abstract][Full Text] [Related]
31. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
32. [Low molecular weight heparins: mechanisms of action and pharmococynetics. Clinical advantages over the classic unfractioned heparins].
Campos M
Rev Port Cir Cardiotorac Vasc; 2003; 10(2):61-7. PubMed ID: 15094887
[TBL] [Abstract][Full Text] [Related]
33. Antithrombotics in thrombosis and cancer.
Mousa SA
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):283-91. PubMed ID: 15030287
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the efficacy of heparins of varying molecular mass and duration of their use in the treatment of patients with acute venous thrombosis.
Kirienko AI; Leont'ev SG; Petukhov EB; Andreiashkin BV; Lebedev IS; Komarova VP
Angiol Sosud Khir; 2004; 10(1):18-28. PubMed ID: 15163985
[TBL] [Abstract][Full Text] [Related]
35. New anticoagulants: a pediatric perspective.
Balasa VV
Pediatr Blood Cancer; 2005 Nov; 45(6):741-52. PubMed ID: 15782418
[TBL] [Abstract][Full Text] [Related]
36. New anticoagulants and their potential impact on the treatment of thromboembolic disease.
Ansell J
Curr Hematol Rep; 2004 Sep; 3(5):357-62. PubMed ID: 15341703
[TBL] [Abstract][Full Text] [Related]
37. Role of current and emerging antithrombotics in thrombosis and cancer.
Mousa SA
Timely Top Med Cardiovasc Dis; 2006 Aug; 10():E19. PubMed ID: 17066136
[TBL] [Abstract][Full Text] [Related]
38. Thromboembolism in cancer patients: pathogenesis and treatment.
Adess M; Eisner R; Nand S; Godwin J; Messmore HL; Wehrmacher WH
Clin Appl Thromb Hemost; 2006 Jul; 12(3):254-66. PubMed ID: 16959679
[TBL] [Abstract][Full Text] [Related]
39. Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitor.
Biemond BJ; Perzborn E; Friederich PW; Levi M; Buetehorn U; Büller HR
Thromb Haemost; 2007 Mar; 97(3):471-7. PubMed ID: 17334516
[TBL] [Abstract][Full Text] [Related]
40. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
